Home › Research › How common it is
Prevalence of Alzheimer’s disease pathology in the community
Dag Aarsland, Anita Lenora Sunde, Diego Tovar, Antoine Leuzy, Tormod Fladby, Henrik Zetterberg, Kaj Blennow, Kübra Tan et al.. Nature, 2025-12-17
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Abstract The prevalence of Alzheimer’s disease neuropathological changes (ADNCs), the leading cause of cognitive impairment, remains uncertain. Recent blood-based biomarkers enable scalable assessment of ADNCs 1 . Here we measured phosphorylated tau at threonine 217 in 11,486 plasma samples from a Norwegian population-based cohort of individuals over 57 years of age as a surrogate marker for ADNCs. The estimated prevalence of ADNCs increased with age, from less than 8% in people 58–69.9 years of age to 65.2% in those over 90 years of age. Among participants aged 70 years or older, 10% had preclinical Alzheimer’s disease, 10.4% had prodromal Alzheimer’s disease and 9.8% had Alzheimer’s disease dementia. Furthermore, among those 70 years of age or older, ADNCs were present in 60% of people with dementia, in 32.6% of those with mild cognitive impairment and in 23.5% of the cognitively unimpaired group. Our findings suggest a higher prevalence of Alzheimer’s disease dementia in older individuals and a lower prevalence of preclinical Alzheimer’s disease in younger groups than previously estimated 2 .
What this study adds
Evidence grade: Moderate
Using plasma p-tau217 as a surrogate marker, the estimated prevalence of Alzheimer's disease neuropathological changes rose with age, from less than 8% in people aged 58–69.9 to 65.2% in those over 90. Reported effect size: 65.2%; 10.4%; 9.8%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Aarsland, D., Sunde, A. L., Tovar, D., Leuzy, A., Fladby, T., Zetterberg, H., et al. (2025). Prevalence of Alzheimer’s disease pathology in the community. Nature. https://doi.org/10.1038/s41586-025-09841-y
Vancouver
Aarsland D, Sunde AL, Tovar D, Leuzy A, Fladby T, Zetterberg H, et al. Prevalence of Alzheimer’s disease pathology in the community. Nature. 2025. doi:10.1038/s41586-025-09841-y. PMID: 41407852.
BibTeX
@article{aarsland2025-41407852,
author = {Aarsland, Dag and Sunde, Anita Lenora and Tovar, Diego and Leuzy, Antoine and Fladby, Tormod and Zetterberg, Henrik and Blennow, Kaj and Tan, Kübra and others},
title = {{Prevalence of Alzheimer’s disease pathology in the community}},
journal = {Nature},
year = {2025},
doi = {10.1038/s41586-025-09841-y},
pmid = {41407852},
url = {https://doi.org/10.1038/s41586-025-09841-y}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Our findings suggest a higher prevalence of Alzheimer’s disease dementia in older individuals and a lower prevalence of preclinical Alzheimer’s disease in younger groups than previously estimated 2 .
Why it matters
Using plasma p-tau217 as a surrogate marker, the estimated prevalence of Alzheimer's disease neuropathological changes rose with age, from less than 8% in people aged 58–69.9 to 65.2% in those over 90. The findings suggest a higher prevalence of Alzheimer's disease dementia in older individuals and a lower prevalence of preclinical Alzheimer's disease in younger groups than previously estimated.
New to this subject? Start with our plain-English guide: Alzheimer's in numbers →
Study details
- Effect size65.2%; 10.4%; 9.8%
- Evidence strengthModerate
How this study scored 61/100
Published in a top-tier journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 10 / 10 | Tier 1 — top-tier general journal (Nature) |
| Journal's citation record | 4 / 4 | Nature: journal h-index 1,841 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 46 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 15.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 5 / 6 | Cited 29.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 4 other studies in this library |
| Still being cited | 2 / 4 | Cited 46 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Nicholas James Ashton: h-index 91 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University College London: institution h-index 2,029 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 30 institution(s) in 12 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41407852) |
| Free to read | 2 / 2 | Free to read |
| Total | 61 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 18.
In the news
1 news article on alzhub's news page cites this paper.
Later studies that cite this one
4 studies in the alzhub library list this one in their references.
Related studies in How common it is from nearby years
Also in How common it is
80 studies in the library are filed under How common it is with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The How common it is hub.